The Brief
- A federal class-action lawsuit accuses three Chicago-based cannabis companies of deceptively marketing marijuana products as treatments for various medical conditions while downplaying potential risks.
- The complaint cites research linking cannabis use to mental health conditions including psychosis, depression, and anxiety, and argues consumers were not adequately warned.
- Verano Holdings disputes the allegations, saying it complies with state regulations and intends to vigorously defend itself in court.
CHICAGO – A federal class-action lawsuit is drawing comparisons between the cannabis industry and Big Tobacco.
The suit alleges three Illinois-based marijuana manufacturers deceptively marketed cannabis products as helping to treat medical conditions while downplaying or failing to adequately warn consumers about potential risks.
The backstory:…